AiCure

R&D Trends

Merck, NewLink Genetics collaborate on investigational Ebola vaccine

Wednesday, November 26, 2014 11:54 AM

Merck and Ames, Iowa-based NewLink Genetics have entered into an exclusive worldwide license agreement to research, develop, manufacture and distribute NewLink’s investigational rVSV-EBOV (Ebola) vaccine candidate.

More... »


Report: AML treatment market to witness modest growth by 2020

Wednesday, November 26, 2014 11:53 AM

The value of the global acute myeloid leukemia (AML) therapeutics market will increase moderately from $632.6 million in 2013 to $878.6 million by 2020, representing a Compound Annual Growth Rate (CAGR) of 4.8%, according to New York-based business intelligence provider GBI Research.

More... »

CenterWatch

Global Ebola relief effort not reaching rural communities

Wednesday, November 26, 2014 11:50 AM

Unprecedented levels of donation to support Ebola-struck Sierra Leone are bypassing many of the places where funding is urgently needed, claim two U.K.-based experts. The independent experts, Dutch sustainability scientist Robert Verkerk, Ph.D., and Sierra Leonean crisis management expert Morris Marah, have just returned from a one-week capacity assessment mission requested by Hon Alpha Kanu, Minister of Information and Communications of Sierra Leone.

More... »

Yabao Pharmaceuticals, MRC Technology partner in China

Wednesday, November 26, 2014 11:49 AM

China-based Yabao Pharmaceutical has inked an exclusive license with MRC Technology, a U.K. medical research charity, to discover, develop and commercialize innovative products targeting a kinase target for neurodegeneration for the treatment of Parkinson's disease.

More... »

Cell Therapy Catapult, partners launch U.K. database of research funding

Monday, November 24, 2014 02:50 PM

The Cell Therapy Catapult, focused on the development of the U.K. cell therapy industry, has collaborated with the U.K. Regenerative Medicine Platform, the Knowledge Transfer Network and the Association of Medical Research Charities to develop a database of U.K. cell therapy research funding.

More... »

Gates Foundation to support Ebola-affected countries, accelerate treatment evaluation

Monday, November 24, 2014 02:46 PM

The Bill & Melinda Gates Foundation, based in Seattle, Wash., will be supporting efforts in Guinea and other Ebola-affected countries to scale up the production and evaluation of convalescent plasma and other convalescent blood products as potential therapies for people infected with the Ebola virus. Various drug candidates also will be evaluated, including the experimental antiviral drug brincidofovir.

More... »

Innovate U.K., Medical Research Council award $47.1M

Monday, November 24, 2014 02:37 PM

Innovate U.K. and the Medical Research Council have awarded over $47.1 million in new funding through the Biomedical Catalyst, part of the U.K. government’s life sciences strategy.

More... »

OncoSec Medical, University of Washington ink research agreement

Friday, November 21, 2014 11:20 AM

OncoSec Medical, a San Diego-based company developing DNA-based intratumoral cancer immunotherapies, has entered a sponsored research agreement (SRA) with the University of Washington to evaluate the immunologic mechanisms of intratumoral DNA IL-12 electroporation.

More... »

Study: global spending on medicines to increase 30% by 2018, to $1.3 trillion

Thursday, November 20, 2014 01:38 PM

More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30% by 2018.

More... »

Genomics England calls on the U.K. research community

Wednesday, November 19, 2014 02:25 PM

Genomics England is inviting applications to join a new Clinical Interpretation Partnership from U.K. researchers, NHS Clinicians and those in training where they will work on the unique data resource from the 100,000 Genomes Project. The goal of the Genomics England Clinical Interpretation Partnership (GeCIP) is to bring together the best researchers in the U.K., alongside their key international collaborators, to ensure maximized potential to gaining new biological insights into rare inherited diseases, cancers and infectious disease.

More... »

Link to survey
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs